Malignant News and Research

RSS
Researchers find beneficial effects of a novel drug in the management of myocardial infarction

Researchers find beneficial effects of a novel drug in the management of myocardial infarction

Genetic analysis suggests the sudden emergence of threatening viruses

Genetic analysis suggests the sudden emergence of threatening viruses

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Exploring microbiome dynamics in esophageal cancer

Exploring microbiome dynamics in esophageal cancer

Oral rinse shows promise in early detection of gastric cancer

Oral rinse shows promise in early detection of gastric cancer

Unraveling the complex pathology of gastric cancer: TP53 loss and extrinsic risk factors

Unraveling the complex pathology of gastric cancer: TP53 loss and extrinsic risk factors

Understanding cancer cell behavior: Cellular contractility modes and tumor aggressiveness

Understanding cancer cell behavior: Cellular contractility modes and tumor aggressiveness

Researchers identify novel biomarkers in renal cell carcinomas

Researchers identify novel biomarkers in renal cell carcinomas

NK cells' role in cancer therapy resistance unveiled

NK cells' role in cancer therapy resistance unveiled

Gut microbiome study challenges established cancer biomarkers, identifies new bacterial links to colorectal cancer

Gut microbiome study challenges established cancer biomarkers, identifies new bacterial links to colorectal cancer

New blood test shows promise in early detection of ovarian cancer

New blood test shows promise in early detection of ovarian cancer

Study identifies molecular pathway in liver cancer development

Study identifies molecular pathway in liver cancer development

Do neighborhood-level disparities in breast cancer–specific survival remain after accounting for individual, tumor, and treatment characteristics?

Do neighborhood-level disparities in breast cancer–specific survival remain after accounting for individual, tumor, and treatment characteristics?

New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases

New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis

New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis

Study reveals how aberrant epigenetic regulation contributes to aggressive pediatric brain tumors

Study reveals how aberrant epigenetic regulation contributes to aggressive pediatric brain tumors

New microfluidic device improves the separation of tumor cells and clusters from malignant effusions

New microfluidic device improves the separation of tumor cells and clusters from malignant effusions

Periostin may be a novel therapeutic target for treating esophageal squamous cell carcinoma

Periostin may be a novel therapeutic target for treating esophageal squamous cell carcinoma

Depression impacts survival rates and quality of life for women with breast cancer

Depression impacts survival rates and quality of life for women with breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.